Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Antibodies

Tag: Antibodies

  • BiotechToday
  • World

MYCN protein expression level in neuroblastoma patients predicts prognosis better

BioTech Today February 3, 2023February 3, 2023

Charvy Rana, Department of Pathology, AIIMS, New Delhi What is MYCN protein? Cancer often involves the inactivation of tumor-suppressor genes and/or over-activation of oncogenes. The MYCN proto-oncogene is one such example, implicated for its amplified or “oncogenic” status in several neuronal and non-neuronal cancers (those of lung, ovaries, prostate, and more)1. Normally expressed during the […]

Read More
  • BiotechToday
  • World

Refrigeration-free COVID-19 vaccines are cultured on plants and bacteria

bioxone September 19, 2021September 19, 2021 1

Sneha Singhal, Jaypee Institute of information technology, Noida COVID-19 vaccine candidates developed by researchers at UC San Diego can withstand the heat. What are their key ingredients? Plant or bacterial viruses. Vaccine technology: We are still in the early phases of developing the new refrigerator-free COVID-19 vaccine. Vaccine candidates stimulated the mice to produce high […]

Read More
  • Biotechnopedia
  • DNA-Tales

ADE: Antibody Assisted Entry of Viruses

DNA tales August 24, 2021August 24, 2021 1

Aayushi Gaur, University Institute of Engineering and Technology, Kurukshetra University Antiviral antibodies, in general, are considered antiviral because they play an important role in the control of virus infections in a variety of ways. But the presence of these antibodies might be advantageous to the virus in some cases. Antibody-dependent enhancement (ADE) of viral infections […]

Read More
  • BiotechToday
  • World

White-tailed deer in Michigan found to contain Covid antibodies!

BioTech Today August 13, 2021August 12, 2021 3

Kanikah Mehndiratta, MSc, University of Glasgow The spread of SARS-CoV-2 has been devastating to human health globally with a recent death count of about 4 million. A major concern amongst scientists has been the reverse zoonosis which could seriously aggravate the spread of the virus. This could also result in newer variants evolving in animal […]

Read More
  • Biotechnopedia
  • DNA-Tales

Goodpasture Syndrome- A Condition affecting One in every Million

DNA tales August 12, 2021August 12, 2021 2

Priasha Dutta, Amity University Kolkata, West Bengal A very rare and life-threatening autoimmune disease, Goodpasture syndrome (GPS) was discovered in 1919 by Dr. Ernest Goodpasture when he reported a case of bleeding in the lungs and glomerulonephritis during an influenza epidemic. Its rate of occurrence is 1 out of 1 million per year. This disorder […]

Read More
  • BiotechToday
  • World

CGRP: A special peptide and its role in Migraine Attacks

BioTech Today August 4, 2021August 4, 2021 1

Sayak Banerjee, Amity University Kolkata Migraine and its chronification: Migraine is a significant primary headache disorder as it ranks the sixth most prevailing disease and the second cause of disability worldwide. This widespread neurological disease is distinguished by headaches which might take place with or without aura. An aura is a kind of sensory disturbance […]

Read More
  • BiotechToday
  • World

High risk of COVID-19 in organ transplant patients

BioTech Today July 29, 2021July 29, 2021

Soumya Shraddhya Paul, Amity University, Noida The extent to which Covid vaccinations can protect people who have organ transplants is yet unknown. Transplantation doctors have long feared that the Covid vaccinations aren’t providing enough protection to patients undergoing transplants. Few studies have suggested that even after being completely vaccinated with mRNA vaccines, which are believed […]

Read More
  • BiotechToday
  • World

A memory B cells atlas against SARS-CoV2 viral variants

BioTech Today July 26, 2021July 25, 2021 1

Kanikah Mehndiratta, MSc, University of Glasgow The SARS-CoV2 virus has been nothing less than devastating to the global population within the last 1 year. The associated COVID-19 (coronavirus disease-2019) is being the center of attention for scientists and doctors worldwide. It helps them understand the underlying pathophysiology so that they can work towards devising appropriate […]

Read More
  • BiotechToday
  • World

Inclusion in HIV Vaccine Trials: A Critical Need

BioTech Today July 19, 2021July 18, 2021 1

Agrima Bhatt, Rajasthan University HIV has been present in our society for more than 30 years, from Central Africa to the USA and around the world. Viruses, as we can observe from 2021, are hard to combat! From the 1700s till today, have we progressed in society to include everyone without prejudice. From this crucial […]

Read More
  • BiotechToday
  • World

Sputnik V- single dose usage against COVID-19

BioTech Today July 16, 2021July 15, 2021 1

Kanikah Mehndiratta, MSc, University of Glasgow Amongst so many vaccine options recently developed in different parts of the world, Sputnik V has proven to be a great candidate due to a lot of factors. Firstly, is its high efficacy of about 92% against the coronavirus disease caused by the SARS-CoV2 viral strains. Also known as […]

Read More

Posts navigation

1 2 3

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy